FDA approves IMAAVY® (nipocalimab-aahu) as first-ever treatment for warm autoimmune hemolytic anemia (wAIHA), representing a landmark advancement for patients - PR Newswire

<a href="https://news.google.com/rss/articles/CBMisgJBVV95cUxOWWhuSXBROXpxLVhpZl…; target="_blank">FDA approves IMAAVY® (nipocalimab-aahu) as first-ever treatment for warm autoimmune hemolytic anemia (wAIHA), representing a landmark advancement for patients</a>&nbsp;&nbsp;<font color="#6f6f6f">PR Newswire</font>